ArticlePharmaceutical science advances2025
Corrigendum to "GLDC interacts with VPS34 to inhibit tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma" [Adv. Pharmaceut. Sci. (3), (2025), 100072].
Zan Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.